세계의 살모넬라 검사 및 치료 시장(2023-2030년)

Title: Global Salmonella Testing and Treatment Market Size, Share & Trends Analysis Report by Testing Method (Culture-based Methods, Molecular-based Methods, and Immunoassays), by Sample Type (Food, Water, and Environmental Surfaces), and by Application (Clinical Diagnostics, Food Safety Testing, and Veterinary Diagnostics)Forecast Period (2023-2030).

The global salmonella testing and treatment market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). Salmonella is a bacterial disease that affects the intestinal tract. Salmonella bacteria typically live in animal and human intestines and are shed through stool (feces). Humans become infected most frequently through polluted water or food. The increasing number of patients suffering from food infection is the primary factor supporting the market growth. According to the Department of Agriculture, Environment and Rural Affairs, over 2,500 strains (serovars) of Salmonella are known most of which rarely cause disease.

Furthermore, certain strains, such as salmonella enteritidis and salmonella typhimurium, may cause human disease. Hence, the increasing awareness among people and government initiatives for the prevention of salmonella infection is another factor driving the salmonella testing and treatment market globally. For instance, in December 2003, Parliament and Council Regulation on the control of salmonella to ensure that proper and effective measures were taken to detect and control Salmonella and other zoonotic agents at all relevant stages of production, processing, and distribution, to reduce their prevalence and the risk they pose to public health.

Segmental Outlook

The global salmonella testing and treatment market is segmented on the testing method, sample type, and application. Based on the testing method, the market is sub-segmented into culture-based Methods, molecular-based Methods, and immunoassays. Based on sample type, the market is sub-segmented into food, water, and environmental surfaces. Further, based on application, the market is sub-segmented into clinical diagnostics, food safety testing, and veterinary diagnostics.

The Molecular-Based Methods Sub-Segment is Anticipated to Hold a Considerable Share of the Global Salmonella Testing and Treatment Market

Among the industry verticals, the molecular-based method sub-segment is expected to hold a considerable share of the global salmonella testing and treatment market. The segmental growth is attributed to the adoption of testing methods such as polymerase chain reaction (PCR), DNA, loop-mediated isothermal amplification (LAMP), Nucleic acid sequence-based amplification (NASBA), recombinase polymerase amplification (RPA) and whole-genome sequencing. For Instance, in March 2012, Abbott collaborated with Genetics Laboratory, Inc. (GenLab) on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections. Under the terms of the agreement, Abbott, in conjunction with GenLab, will develop and commercialize the new assay for use on the PLEX-ID™ automated microbial identification system.

Regional Outlook

The global salmonella testing and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, European Union has specific regulations in place for Salmonella testing in various food categories, such as poultry and eggs, and also has a focus on food safety and implements strict regulations for ensuring the quality of food products.

The North America Region is Expected to Grow at a Significant CAGR in the Global Salmonella Testing and Treatment Market

Among all regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to a high prevalence of food-borne illnesses in North America. According to the Centers for Disease Control and Prevention (CDC), the US estimates that Salmonella is responsible for 1.4 million infections, 26,500 hospitalizations, and 420 fatalities. With the creation of the Interagency Food Safety Analytics Collaboration (IFSAC) in 2011; CDC, the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS) agreed to improve data and methods used to estimate foodborne illness source attribution and provide timely estimates of the food sources of four priority foodborne pathogens: Salmonella, Escherichia coli O157, Listeria monocytogenes and Campylobacter.

Market Players Outlook

The major companies serving the salmonella testing and treatment market include Abbott, Eiken Chemical Co., Ltd., GlaxoSmithKline, 3M, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2017, Merck KGaA acquired Biocontrol to Strengthen its Position in food safety testing the global spotlight on the importance of food safety has grown given the increased incidents of outbreaks and recalls with foodborne diseases often caused by consuming a wide range of foods including undercooked meat, eggs, fresh produce and dairy products contaminated by Salmonella, Listeria, E. coli O157H7 and Campylobacter.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global salmonella testing and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Abbott
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Eiken Chemical Co., Ltd.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. GlaxoSmithKline
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Salmonella Testing and treatment Market by Testing Method
  • 4.1.1. Culture-Based Methods
  • 4.1.2. Molecular-Based Methods
  • 4.1.3. Immunoassays
• 4.2. Global Salmonella Testing and treatment Market by Sample Type
  • 4.2.1. Food
  • 4.2.2. Water
  • 4.2.3. Environmental Surfaces
• 4.3. Global Salmonella Testing and treatment Market by Application
  • 4.3.1. Clinical Diagnostics
  • 4.3.2. Food Safety Testing
  • 4.3.3. Veterinary Diagnostics

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. 3M Co.
• 6.2. Becton, Dickinson, and Company
• 6.3. Biomerieux
• 6.4. Bio-Rad Laboratories, Inc.
• 6.5. Enzo Life Sciences, Inc.
• 6.6. Hardy Diagnostics
• 6.7. IDEXX Laboratories, Inc.
• 6.8. Merck KGaA
• 6.9. Mylab Discovery Solutions Pvt. Ltd.
• 6.10. PerkinElmer Inc.
• 6.11. Shimadzu Diagnostics Corp.
• 6.12. Thermo Fisher Scientific Inc.